Presentation TCT 2013 Position Statement: Given the Advances in Stent Technology, Pharmacology, Imaging and Technique, All the Prior PCI vs. CABG Trials Are Archaic and Obsolete! Presenter: Dean Kereiakes October 29, 2013
Presentation TCT 2013 Early Vascular Restoration following treatment of single de-novo coronary artery lesions with the DESolve Nx Novolimus Eluting Bioresorbable Coronary Scaffold System (NEBCSS) at 6 months: Insights... Presenter: J. Ribamar Costa Jr. October 29, 2013
Presentation TCT 2013 Case Presentation 3: Primary PCI with a Complex Bifurcation of the Left Main Presenter: Miroslav Vytiska October 29, 2013
Presentation TCT 2013 TCT-21. Prognosis of Clinical Outcomes in Chinese Patients Receiving XIENCE V Everolimus-Eluting Stent with Baseline and Residual Syntax Score: One-Year Results from the... Presenter: Yuejin Yang October 29, 2013
Presentation TCT 2013 CoreValve US Pivotal Study Design and Extreme Risk Results Presenter: Steven Yakubov October 29, 2013
Presentation TCT 2013 Case #2: Management of Acute MI with Cardiogenic Shock and Multivessel Coronary Disease Presenter: Eric Van Belle October 29, 2013
Presentation TCT 2013 TCT-8. 6-month versus 12-month dual antiplatelet therapy after implantation of 2nd generation drug-eluting stents with Biolimus-eluting Versus Zotarolimus-eluting stent:... Presenter: Byoung Kwon Lee October 29, 2013
Presentation TCT 2013 Long-Term Outcomes of Percutaneous Left Ventricular Pseudoaneurysm Closure Presenter: Robert Kumar October 29, 2013
Presentation TCT 2013 TCT-59. Longer term safety and efficacy of sympathetic renal artery denervation using a multi-electrode renal artery denervation catheter in patients with drug-resistant... Presenter: Stephen Worthley October 29, 2013
Presentation TCT 2013 TCT-116. Prosthesis-Patient Mismatch after Aortic Valve-In-Valve Implantation: Insights from the Global Valve-in-Valve Registry Presenter: Sabine Bleiziffer October 29, 2013